Investor Presentaiton

DNA Operative CAPEX in 2018 in the reference year level Operative capex 1 was 22.7% of net sales in October-December EUR million 137 133 135 28.7% 22.7% 15.9% 15.0% 14.7% 67 54 2016 2017 2018 Operative Capex as a % of Revenue 22.7% 54 Key highlights in October-December 2018 & FY2018 ☐ Operative capital expenditure decreased from the reference period and was EUR 53.8 million (67.3), or 22.7% of net sales (28.7%) Operative Capex in 2018 remained at a similar level than in 2017 and was 14.7% of net sales ■ Capital expenditures was distributed more evenly throughout the year in 2018 Major individual items included in capital expenditure in the review period are 4G network capacity expansion, fibre optics networks and transmission systems 4Q/2017 4Q/2018 4Q/2018* Operative Capex Notes 1. Operative capital expenditure is reported capital expenditure excluding cash instalments for spectrum licenses capitalized. *Including IFRS 15 DNA's Investor presentation, February 2019 28

View entire presentation